Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,257,088 papers from all fields of science
Search
Sign In
Create Free Account
mocimycin
Known as:
delvomycin
, kirromycin
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Anti-Bacterial Agents
Pyridones
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Sequential asymmetric polyketide heterocyclization catalyzed by a single cytochrome P450 monooxygenase (AurH).
Martin E. A. Richter
,
Nelly Traitcheva
,
U. Knüpfer
,
C. Hertweck
Angewandte Chemie
2008
Corpus ID: 42189092
Complex polyketide metabolites, such as macrolides, polyenes, and polyethers, are an important source of novel therapeutics or…
Expand
1995
1995
Relevance of histidine‐84 in the elongation factor Tu GTPase activity and in poly(Phe) synthesis: Its substitution by glutamine and alanine
Giuliana Scarano
,
I. Krab
,
V. Bocchini
,
A. Parmeggiani
FEBS Letters
1995
Corpus ID: 25005513
1989
1989
Structure-function relationships of elongation factor Tu. Isolation and activity of the guanine-nucleotide-binding domain.
M. Jensen
,
R. Cool
,
K. Mortensen
,
B. Clark
,
A. Parmeggiani
European Journal of Biochemistry
1989
Corpus ID: 42840533
The guanine-nucleotide-binding domain (G domain) of elongation factor Tu(EF-Tu) consisting of 203 amino acid residues…
Expand
1986
1986
Characterization of the elongation factors from calf brain. 2. Functional properties of EF-1 alpha, the action of physiological ligands and kirromycin.
J. Créchet
,
A. Parmeggiani
European Journal of Biochemistry
1986
Corpus ID: 24565230
The properties of EF-1 alpha from calf brain have been investigated and compared with those of EF-Tu. EF-1 alpha binds GDP and…
Expand
Highly Cited
1984
Highly Cited
1984
Cross-linking of tRNA at two different sites of the elongation factor Tu.
J. van Noort
,
B. Kraal
,
L. Bosch
,
T. la Cour
,
J. Nyborg
,
B. Clark
Proceedings of the National Academy of Sciences…
1984
Corpus ID: 26605373
Recently, we reported on the induction by kirromycin of two tRNA binding sites on elongation factor Tu. To obtain independent…
Expand
Highly Cited
1981
Highly Cited
1981
Location of the tufB promoter of E. coil: Cotranscription of tufB with four transfer RNA genes
Jong S. Lee
,
G. An
,
J. Friesen
,
N. Fill
Cell
1981
Corpus ID: 35934526
1981
1981
A kirromycin resistant elongation factor EF‐Tu from Escherichia coli contains a threonine instead of an alanine residue in position 375
F. Duisterwinkel
,
J. de Graaf
,
Kraal Barend
,
Bosch Leendert
FEBS Letters
1981
Corpus ID: 28101297
1981
1981
Two elongation factors from the extremely halophilic archaebacterium Halobacterium cutirubrum. Assay systems and purification at high salt concentrations.
M. Kessel
,
F. Klink
European Journal of Biochemistry
1981
Corpus ID: 25275335
Two peptide chain elongation factors from Halobacterium cutirubrum were purified nearly to homogeneity. They were identified and…
Expand
1980
1980
Elongation factor Tu isolated from Escherichia coli mutants altered in TufA and tufB.
P. H. van der Meide
,
T. Borman
,
A. V. Van Kimmenade
,
P. Van de Putte
,
L. Bosch
Proceedings of the National Academy of Sciences…
1980
Corpus ID: 24433779
In a previous paper we described a number of Escherichia coli mutants resistant to the antibiotic kirromycin. These mutants are…
Expand
Highly Cited
1978
Highly Cited
1978
Modification of elongation-factor-Tu . guanine-nucleotide interaction by kirromycin. A comparison with the effect of aminoacyl-tRNA and elongation factor Ts.
O. Fasano
,
W. Bruns
,
J. Créchet
,
G. Sander
,
A. Parmeggiani
European Journal of Biochemistry
1978
Corpus ID: 21211564
Kirromycin activates functions of elongation factor Tu (EF-Tu) that normally require the presence of specific effectors [Wolf et…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE